These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diagnostic utility of LMO2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma. Bansal D; Pasricha S; Gupta G; Sharma A; Durga G; Kamboj M; Mehta A Indian J Pathol Microbiol; 2024; 67(1):141-144. PubMed ID: 38358204 [TBL] [Abstract][Full Text] [Related]
4. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2. Pozdnyakova O; Orazi A; Kelemen K; King R; Reichard KK; Craig FE; Quintanilla-Martinez L; Rimsza L; George TI; Horny HP; Wang SA Am J Clin Pathol; 2021 Feb; 155(2):160-178. PubMed ID: 33367495 [TBL] [Abstract][Full Text] [Related]
5. Myeloid and lymphoid neoplasm with novel complex translocation: unusual case report with T-lymphoblastic lymphoma, myeloid hyperplasia, eosinophilia, basophilia, and t(1;8;10)( (p31;q24;q11.2). Aljabry MS J Hematop; 2023 Mar; 16(1):27-31. PubMed ID: 38175368 [TBL] [Abstract][Full Text] [Related]
6. Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma. Akiely R; Almasri F; Almasri N; Abu-Ghosh A Front Pediatr; 2022; 10():1059527. PubMed ID: 36589160 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Utility of the Germinal Center-associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms. Menter T; Gasser A; Juskevicius D; Dirnhofer S; Tzankov A Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):491-8. PubMed ID: 25203428 [TBL] [Abstract][Full Text] [Related]
8. sTRBC1 and cyTRBC1 Expression Distinguishes Indolent T-Lymphoblastic Proliferations From T-Lymphoblastic Leukemia/Lymphoma. Liu J; Li M; Fu J; Dong M; Fan X; Zhong L; Xu G; Li Y; Xi Q Am J Surg Pathol; 2023 Nov; 47(11):1325-1331. PubMed ID: 37515427 [TBL] [Abstract][Full Text] [Related]
9. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1. Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675 [TBL] [Abstract][Full Text] [Related]
10. A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia/lymphoma without eosinophilia. Oberley MJ; Denton C; Ji J; Hiemenz M; Bhojwani D; Ostrow D; Wu S; Gaynon P; Raca G Cancer Genet; 2017 Oct; 216-217():91-99. PubMed ID: 29025601 [TBL] [Abstract][Full Text] [Related]
11. LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma. Jevremovic D; Roden AC; Ketterling RP; Kurtin PJ; McPhail ED Am J Clin Pathol; 2016 Feb; 145(2):180-90. PubMed ID: 26796495 [TBL] [Abstract][Full Text] [Related]
12. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement. Shao H; Wang W; Song J; Tang G; Zhang X; Tang Z; Srivastava J; Shah B; Medeiros LJ; Zhang L Leuk Res; 2020 Dec; 99():106460. PubMed ID: 33166908 [TBL] [Abstract][Full Text] [Related]
13. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients]. Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455 [TBL] [Abstract][Full Text] [Related]
15. Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens. Khurana S; Melody ME; Ketterling RP; Peterson JF; Luoma IM; Vazmatzis G; Tun HW; Foran JM; Jiang L Cancer Genet; 2020 Jan; 240():40-44. PubMed ID: 31739126 [TBL] [Abstract][Full Text] [Related]
16. Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. Agostinelli C; Paterson JC; Gupta R; Righi S; Sandri F; Piccaluga PP; Bacci F; Sabattini E; Pileri SA; Marafioti T Histopathology; 2012 Jul; 61(1):33-46. PubMed ID: 22394247 [TBL] [Abstract][Full Text] [Related]
19. NOTCH1 intracellular domain immunohistochemistry as a diagnostic tool to distinguish T-lymphoblastic lymphoma from thymoma. Jegalian AG; Bodo J; Hsi ED Am J Surg Pathol; 2015 Apr; 39(4):565-72. PubMed ID: 25517959 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of HGAL and LMO2 immunohistochemistry in the identification of follicular lymphomas of the non-gastric gastrointestinal tract. Chapman-Fredricks J; Younes SF; Fan YS; Sandoval-Sus JD; Natkunam Y; Lossos IS Appl Immunohistochem Mol Morphol; 2013 May; 21(3):200-4. PubMed ID: 22914613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]